CMS Proposes Major Increase in Reimbursement for Canaloplasty, page-468

TheAnalyst007 gets very excited about fundamentals but doesn't quote any. Funny guy. This business has net tangible asset backing of 2 cents per share, last half net loss of $2.95 per share, sales of $10 mil and expenses of $16 mil. It is rated high risk and recently raised $8 mil but given its cash burn will need to again before it gets to cashflow neutrality somewhere in the next 2 years. I'd wait until it starts showing some promise, it's not there yet. Trading at 25% below its 52 week high and 91% above its 52 week low in an ebullient market, I'd be cautious about expecting too much, given the likelihood of some sort of volatility, which this company is highly susceptible to. My 2 cents won't be popular lol